>The increased plasma mir-21 expression level could be a novel biomarker for the severity of coronary artery stenosis and correlation with aging, and mir-21 inhibition prevents HUVEC cellular injuries under hypoxia-reoxygenation insults via targeting PDCD4, suggesting a potential target for treating atherosclerotic CAD patients. This evidence concerns the gene PDCD4 and coronary stenosis.